Protein Engineering And Sitedirected Mutagenesis
Rapid developments in the technique of site-directed mutagenesis have created the ability to change essentially any amino acid, or even substitute or delete whole domains, in any protein, with the goal of designing and constructing new proteins with novel binding, clearance, or catalytic activities 31, 32 . The concomitant changes in protein folding and tertiary structure, protein physiology, binding affinities for a receptor or hormone , binding specificities either for substrate or receptor ,...
Ho Oh
profile of different protected monosaccharides to determine the outcome 103 . The reactivity of a monosaccharide is highly dependent on the protecting groups and the anomeric-acti-vating group used. By adding substrates in sequence from most reactive to least reactive, the predominance of a desired target compound is assured. The key to this approach is to have extensive quantitative data regarding the relative reactivities of different protected monosac-charides. Thus, a reactivity database on...
Passive Diffusion
In general, drug transport across any epithelium is dictated by the characteristics of the cell membrane and the physicochemical prop erties of drugs. In absorptive epithelia such as enterocytes, the intercellular space is sealed by tight junctions or zonula occludens ZO . The junctional proteins ZO-1 and ZO-2 play essential roles in epithelial barrier function they not only maintain cell polarity by confining surface proteins to their appropriate membrane domains but also prevent diffusion of...
Combinatorial Approaches to Oligonucleotide Therapeutics
At least two methods by which oligonucleo-tides can be created combinatoriallyhave been published 64-66 .The potential advantage of a combinatorial approach is that oligonucle-otide-based molecules can be prepared to adopt various structures that support binding to nonnucleic acid targets as well as nucleic acid targets. These can then be screened for potential activities without knowledge about the cause of the disease or the structure of the target. 2.6 The Medicinal Chemistry of...
Ho Tqz
ficacy of hyaluronic acid in the treatment of osteoarthritis of the knee and other large joints. In addition to restoring the elasticity and viscosity of the synovial fluid, hyaluronic acid modulates acute and chronic inflammation processes both in animals and human beings 31 . Specifically, hyaluronic acid interacts with endogenous receptors such as CD 44, ICAM-1, and RHAMM and may play an important role in controlling a variety of cellular behaviors, such as the migration, adhesion, and...
Pgp
Interestingly, there has been over a decade's worth of studies that have identified pharmacophores for this efflux pump that could have been used to help predict P-gp-related bioavailability issues. Early computational studies using P-gp modulators such as verapamil, reserpine, 18-epireserpine, and TMBY showed that they could be aligned, suggesting the importance of aromatic rings and a basic nitrogen atom in P-gp modulation 174, 175 . Asubsequent, more extensive study with 232 phenothiazines...
Membrane Transport Proteins and Drug Transport
OSU Heart amp Lung Institute Core Laboratory for Bioinformatics and Computational Biology The Ohio State University Columbus, Ohio Burger's Medicinal Chemistry and Drug Discovery Sixth Edition, Volume 2 Drug Development Edited by Donald J. Abraham ISBN 0-471-37028-2 2003John Wiley amp Sons, Inc. 2 Strategies to Enhance Drug Permeability, 251 2.2 Lipid-Based Oral Drug Delivery, 252 2.3.1 Definition of Prodrugs, 253 2.3.2 Prodrug Design by Increasing Lipophilicity, 253 2.3.3 Rationale and...
References Ivu
1. J. Liebenau, in C. Hansch, P. G. Sammes, and J. B. Taylor, Eds., Comprehensive Medicinal Chemistry, vol. 1, Pergamon Press, Oxford, 1990, pp. 81-98. 2. A. Burger, in C. Hansch, P. G. Sammes, and J. B. Taylor, Eds., Comprehensive Medicinal Chemistry, vol. 1, Pergamon Press, Oxford, 1990, pp. 1-5. 3. W. Sneader, in C. Hansch, P. G. Sammes, and J. B. Taylor, Eds., Comprehensive Medicinal Chemistry, vol. 1, Pergamon Press, Oxford, 1990. 4. L. H. Sterbach, Prog. Drug Res., 22,229-266 1978 . 5. C....
StructureActivity Relationship
Initial understanding of streptomycin structure-activity relationships can be gleaned from comparing the activities of the component rings in groupings. Rings I and II alone are sufficient for antibiotic activity,' but rings II and III streptobiosamine together are inactive this in part explains the high tolerance of ring III for modifications 37 . Figure 6.2 highlights permissible and non-permissible alterations to streptomycin and analogs. Within the streptamine ring, any change to the...
Streptomycin
Streptomycin and other antibiotics that are close analogs Fig. 6.1 all contain a streptamine aminocyclitol, which is linked to a streptose ring, which in turn is linked to an N-methylglucosamine. Of the 10 natural streptomycin-like compounds listed in Fig. 6.1, all have guanidino groups at the Cl and C3 position except for bluensomycin, which contains a carbamoyl group at the Cl position instead. Some variation is tolerated within the streptose ring the aldehyde can be reduced to an alcohol,...
Meth0xyethyl Chimeras Secondgeneration Antisense Drugs
The 2'-0- 2-methoxyethyl Fig. 5.11 substitution represents a significant advance in an- Figure 5.10. PNA peptide nucleic acid without A and with Lys end B . tisense therapeutics and the culmination of more than a decade of progress in antisense technology. Although oligonucleotides in which every nucleotide contains a 2'-0- 2-methoxyethyl modification have proved of great value when used for occupancy-only-mediated mechanisms e.g., induction of alternative splicing for review, see Ref. 361 ....
O Daj
boring group participation from the 2 position. With acyl type protecting groups at C-2, the reaction proceeds through an acyloxonium cation intermediate that reacts with a nucleo-phile to give 1,2-trans stereochemistry in the product, whereas the oxocarbonium ion is expected to give mixtures of the 1,2-cis and 1,2-trans products Scheme 7.1 . For the synthesis of 1,2-cis glycosides, a prerequisite is the use of non-participating blocking groups at the 2 position. Using a non-participating...
References 1
1. S. Arlington, Pharmaceut. Execut., 20, 74-84 2000 . 2. P. K. Banerjee and M. Rosofsky, Scrip Magazine, 6, 35-38 1997 . 3. A. Fleming, Br. J. Exp. Med., 10, 226-236 1929 . 4. J. W. Black, W. A. M. Duncan, L. J. Durant, J. C. Emmett, C. R. Ganellin, and M. E. Parsons, Nature, 236,385-390 1972 . 5. A. D. Buss and R. D. Waigh, Burger's Medicinal Chemistry and Drug Discovery, 5 th ed., vol. 1, John Wiley amp Sons, New York, 1995, pp. 831033. 6. W. H. Lewis in H. N. Niggand D. Seigler, Eds.,...
Erythromycin And Analogs
Isolation of macrolides began in the 1950s with the discovery of pikromycin 90 the iso lation of numerous other macrolides quickly followed and the search for others continues today. Natural macrolides contain a highly substituted 12- to 16-member monocycle lactone ring, referred to as an aglycone, to which one or more deoxysugars are attached. Erythromycin, the first clinically used macrolide, was isolated in 1953 from Saccharoplyspora erythraea formerly Streptomyces erythreus 91 ....
h 1
5'-hycli'oxystreptomycin lacking ring III Figure 6.1. The structures of streptomycin and several natural analogs of streptomycin. which have been synthesized and tested. The aldehyde oxygen forms a hydrogen bond with a phosphate oxygen of G527. Conversion of the aldehyde to an acid or reduction to a methyl abolishes all activity 45, 46 . Numerous groups have investigated conversion of the aldehyde to its amino derivative and a variety of alkylamine derivatives, with surprising results 47-50 ....
Genetically Engineered Drug Discovery Tools
An increasingly important application of recombinant technology lies not in new protein drug product discovery per se but in the ability to provide cloned and expressed proteins as reagents for medicinal chemistry investigations. The common practice of in vitro screen-ingfor enzyme activity or receptor binding using animal tissue homogenates nonhuman, and therefore nontarget has begun to give way to the use of solid-phase or whole-cell binding assays based on recombinantly produced and isolated...
Info Esg
LogP calculated using HINT 135 .All alkylamines were treated as ammoniumions, which at least for paromomycin and gentamicin ICa underestimates LogP. 6Sum cf OH and NH H-bonds donors 132 . Sum of O and N H-bond acceptors 132 . Computational alert accordingto rule of 5 0, no problem , poor absorption or permeation likely 132 . LogP calculated using HINT 135 .All alkylamines were treated as ammoniumions, which at least for paromomycin and gentamicin ICa underestimates LogP. 6Sum cf OH and NH...
Aminoglycoside Toxicity
All aminoglycosides, including streptomycin, have the potential to produce irreversible vestibular and cochlear intoxication 16 . Non-streptomycin aminoglycosides are also renally toxic 16 . The underlying causes of aminoglycoside ototoxicity are unresolved reviewed in Ref. 71 . Multiple hypotheses exist to explain aminoglycoside ototoxicity, but none are com pletely satisfactory indeed, multiple mechanisms may be at work. One of the two most complete theories states that redox-active...
HighThroughput Screening for Lead Discovery
John G. Houston Maetyn N. Banks Bristol-Myers Squibb Pharmaceutical Research Institute Wallingford, Connecticut Burger's Medicinal Chemistry and Drug Discovery Sixth Edition, Volume 2 Drug Development Edited by Donald J. Abraham ISBN 0-471-37028-2 2003 John Wiley amp Sons, Inc. 2 History of Lead Discovery and Screening, 38 3.1 Target Discovery and Validation, 42 3.1.1 Gene Function by Homology to Other Defined Genes, 43 3.1.2 Gene Function by Gene Subtraction, 43 3.1.3 Gene Function by...